Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Olsen, E A; Whittaker, S J; Kim, Y H; Duvic, M; Prince, H M; Lessin, S R; Wood, G S; Willemze, R; Demierre, M F; Pimpinelli, N; Bernengo, M G; Ortiz-Romero, P L; Bagot, M; Estrach, T; Guitart, J; Knobler, R; Sanches, J A; Iwatsuki, K; Sugaya, M; Dummer, R; Pittelkow, M; Hoppe, R; Parker, S; Geskin, L; Pinter-Brown, L; Girardi, M; Burg, G; Ranki, A; Vermeer, M H; Horwitz, S; Heald, P; Rosen, S; Cerroni, L; Dreno, B; Vonderheid, E C (2011). Clinical end points and response criteria in mycosis fungoides and sezary syndrome: a consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer. Journal of Clinical Oncology, 29(18):2598-2607.

Kempf, W; Pfaltz, K; Vermeer, M H; Cozzio, A; Ortiz-Romero, P L; Bagot, M; Olsen, E; Kim, Y H; Dummer, R; Pimpinelli, N; Whittaker, S; Hodak, E; Cerroni, L; Berti, E; Horwitz, S; Prince, H M; Guitart, J; Estrach, T; Sanches, J A; Duvic, M; Ranki, A; Dreno, B; Ostheeren-Michaelis, S; Knobler, R; Wood, G; Willemze, R (2011). EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood, 118(15):218-225.

Senff, N J; Zoutman, W H; Vermeer, M H; Assaf, C; Berti, E; Cerroni, L; Espinet, B; de Misa Cabrera, R F; Geerts, M L; Kempf, W; Mitchell, T J; Paulli, M; Petrella, T; Pimpinelli, N; Santucci, M; Whittaker, S J; Willemze, R; Tensen, C P (2009). Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. Journal of Investigative Dermatology, 129(5):1149-1155.

This list was generated on Sat Oct 21 13:27:30 2017 CEST.